...
首页> 外文期刊>The Korean Journal of Parasitology >Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickens.
【24h】

Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickens.

机译:携带最大艾美球虫Gam56抗原基因的DNA疫苗对鸡球虫病的功效。

获取原文
获取原文并翻译 | 示例
           

摘要

To control coccidiosis without using prophylactic medications, a DNA vaccine targeting the gametophyte antigen Gam56 from Eimeria maxima in chickens was constructed, and the immunogenicity and protective effects were evaluated. The ORF of Gam56 gene was cloned into an eukaryotic expression vector pcDNA3.1(zeo)+. Expression of Gam56 protein in COS-7 cells transfected with recombinant plasmid pcDNA-Gam56 was confirmed by indirect immunofluorescence assay. The DNA vaccine was injected intramuscularly to yellow feathered broilers of 1-week old at 3 dosages (25, 50, and 100 micro g/chick). Injection was repeated once 1 week later. One week after the second injection, birds were challenged orally with 5x104 sporulated oocysts of E. maxima, then weighed and killed at day 8 post challenge. Blood samples were collected and examined for specific peripheral blood lymphocyte proliferation activity and serum antibody levels. Compared with control groups, the administration of pcDNA-Gam56 vaccine markedly increased the lymphocyte proliferation activity (P<0.05) at day 7 and 14 after the first immunization. The level of lymphocyte proliferation started to decrease on day 21 after the first immunization. A similar trend was seen in specific antibody levels. Among the 3 pcDNA-Gam56 immunized groups, the median dosage group displayed the highest lymphocyte proliferation and antibody levels (P<0.05). The median dosage group had the greatest relative body weight gain (89.7%), and the greatest oocyst shedding reduction (53.7%). These results indicate that median dosage of DNA vaccine had good immunogenicity and immune protection effects, and may be used in field applications for coccidiosis control.
机译:为了在不使用预防药物的情况下控制球虫病,构建了针对鸡的Eimeria maxima配子体抗原Gam56的DNA疫苗,并评估了其免疫原性和保护作用。将Gam56基因的ORF克隆到真核表达载体pcDNA3.1(zeo)+中。通过间接免疫荧光测定证实了在重组质粒pcDNA-Gam56转染的COS-7细胞中Gam56蛋白的表达。将DNA疫苗以3种剂量(25、50和100微克/只)肌肉注射到1周龄的黄色羽毛肉鸡上。 1周后重复注射一次。第二次注射后一周,用5x10 4 发芽的大肠埃希氏菌卵囊口服攻击鸡,然后在称重后第8天称重并杀死。收集血液样品并检查特异性外周血淋巴细胞增殖活性和血清抗体水平。与对照组相比,pcDNA-Gam56疫苗的接种在首次免疫后第7天和第14天显着提高了淋巴细胞增殖活性(P <0.05)。第一次免疫后第21天,淋巴细胞增殖水平开始下降。在特异性抗体水平上观察到类似趋势。在3个pcDNA-Gam56免疫组中,中位剂量组显示出最高的淋巴细胞增殖和抗体水平(P <0.05)。中值剂量组相对体重增加最大(89.7%),卵囊脱落减少最大(53.7%)。这些结果表明,DNA疫苗的中等剂量具有良好的免疫原性和免疫保护作用,可用于球虫病控制的现场应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号